Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
4,191,000
|
3,736,000
|
4,443,000
|
5,251,000
| Cost of Revenue | 1,075,000 | 987,000 | 1,245,000 | 1,303,000 | |
Gross Profit
|
3,116,000
|
2,749,000
|
3,198,000
|
3,948,000
| |
|
Operating Expenses |
|
Research Development | 1,082,000 | 951,000 | 962,000 | 909,000 |
|
Selling General and Administrative | 1,355,000 | 1,238,000 | 1,228,000 | 1,196,000 |
|
Non Recurring | 51,000 | 1,909,000 | 20,000 | (150,000) |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
628,000
|
(1,349,000)
|
988,000
|
1,993,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 35,000 | 50,000 | 18,000 | (23,000) |
|
Earnings Before Interest And Taxes | 513,000 | (1,259,000) | 1,059,000 | 2,027,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 513,000 | (1,259,000) | 1,059,000 | 2,027,000 |
|
Income Tax Expense | (411,000) | (546,000) | 251,000 | 545,000 |
|
Minority Interest | 1,000 | 2,000 | (163,000) | (381,000) |
|
|
|
Net Income From Continuing Ops | 775,000 | (671,000) | 698,000 | 1,158,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
925,000
|
(711,000)
|
645,000
|
1,101,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
925,000
|
(711,000)
|
645,000
|
1,101,000
|
|